Local therapy can work as well as systemic therapy in uveitis management, with shorter-acting steroid agents working better for acute disease and longer-acting agents working better for recurring disease, according to a speaker.
“One size does not fit all in uveitis,” Thomas A. Albini, MD, said at the virtual OSN New York Retina meeting. “You really need to tailor specific treatment plans to specific patients.”
Local therapy is also largely limited by local side effects, Albini said.
In short-acting depot therapies, one should be aware of the “sawtooth phenomenon,”
Uncategorized